Q

Quanticate

Clinical data management and analysis services

Senior Proposals Manager

Full-TimeUpdated on 10/17/2026
No salary listed
Senior
Bachelor's
Remote in UK
Remote
Project & Program ManagementProposal Management

About the job

Requirements
  • Significant experience preparing full-service clinical proposals within a contract research organization environment.
  • Strong commercial awareness and a proven ability to manage complex proposals and budgets.
  • Experience with multiple pricing models and client bid grids.
  • A background in a commercial or service-led organization within life sciences or pharmaceuticals.
  • Ability to manage competing priorities while meeting deadlines.
  • Strong written and verbal communication skills and attention to detail.
  • A confident interpersonal style and professional telephone manner.
  • Proficiency with standard office applications and customer relationship management systems.
  • Ability to lead and motivate others.
  • Degree qualification or equivalent.
Responsibilities
  • Prepare high-quality budgets and proposals to support global business development activities.
  • Review and quality-check study budgets, proposals, requests for information, and related client responses before submission.
  • Partner with Heads of Function to define bidding strategies, including operational and pricing approaches.
  • Support account management and operational activities, including business wins and revenue recognition.
  • Maintain and oversee sales and finance tracking tools to ensure accurate pipeline reporting.
  • Own and manage the opportunity management system, including Salesforce.
  • Contribute to and deliver training for sales and operational teams on bidding procedures and process compliance.
  • Lead, train, and develop the Proposals team, setting clear standards and expectations.
  • Support the development and implementation of new tools and processes to enhance proposal efficiency and quality.
  • Work closely with the Global Business Development team, operations, finance, and senior stakeholders to develop competitive, compliant bids, budgets, and pricing strategies.
  • Manage and continuously improve proposal-related processes.

About the company

Quanticate is a global data-focused CRO that supports pharmaceutical, biotechnology, and medical device companies with the data side of clinical trials. It handles Clinical Data Management, Biostatistics, SAS Programming, data quality oversight via Centralized Statistical Monitoring, Medical Writing, and Pharmacovigilance, offering study-level support, functional service provision, strategic data-solutions, or technical consultancy. Its staff work on trial data to clean and organize it, perform analyses, write reports, and monitor quality, delivered through flexible models like dedicated teams, project-based work, or full data solutions. The goal is to be the supplier of choice for data-driven clinical research by delivering accurate, timely, and compliant data solutions that help speed and improve decision-making in trials.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Hitchin, United Kingdom

Founded

1994

Get referred to Quanticate

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quanticate updated its site in 2026, signaling active operations and continued talent investment.
  • The PhaseV service launched April 2024 targets adaptive trials, a higher-value niche for sponsors.
  • Cancer Research UK collaboration on DETERMINE links Quanticate to precision-oncology trial demand.

What critics are saying

  • Big pharma cuts at Novo Nordisk, Bayer, and Moderna squeeze CRO budgets through 2026.
  • Quanticate's 2024 partnerships are not proprietary products, so competitors can copy the model fast.
  • If sponsor demand weakens, this services-only CRO faces margin compression and hiring freezes by 2026.

What makes Quanticate unique

  • Quanticate pairs biostatistics, statistical programming, and clinical data management under one CRO.
  • The April 2024 PhaseV alliance adds adaptive-trial optimization software to its service stack.
  • Leadership pages show experienced operators, including Richard Morton and Sundar Ramamoorthy, across UK, US, India.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Flexible Work Hours
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Health Insurance
  • Disability Insurance
  • Training Programs

Company News

Quanticate
Apr 25th, 2024
Quanticate announces strategic partnership with PhaseV

Quanticate announces strategic partnership with PhaseV.

World Pharma Today
Jun 2nd, 2023
Quanticate announces strategic partnership with KPS Life | World Pharma Today

Quanticate, a global biometric clinical research organization, is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight.

Quanticate
Mar 7th, 2023
Quanticate is finalist at the Citeline Awards 2023

Quanticate is pleased to announce that Quanticate Inc. has been selected as a finalist for the Excellence in Use of Real-World Evidence category in the Citeline Awards 2023.

World Pharma Today
Jan 27th, 2023
Quanticate makes key appointment to bolster leadership team | World Pharma Today

Quanticate, a global data-focused clinical research organisation (CRO), has announced the appointment of Yolanda Barbachano as Head of Statistics.

PharmiWeb
Sep 27th, 2022
Quanticate Partners With Cancer Research Uk To Launch Determine Study

Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells. The first of its kind in the UK, the DETERMINE study will enrol patients with rare cancers, and aim to find out whether existing licensed drugs could be used to treat their type of cancer